Relationships between coagulation factors and thrombin generation in a general population with arterial and venous disease background

Pauline C S van Paridon, Marina Panova-Noeva, Rene van Oerle, Andreas Schulz, Jürgen H Prochaska, Natalie Arnold, Irene Schmidtmann, Manfred Beutel, Norbert Pfeiffer, Thomas Münzel, Karl J Lackner, Hugo Ten Cate, Philipp S Wild, Henri M H Spronk

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

BACKGROUND: The current study aims to identify the relationships between coagulation factors and plasma thrombin generation in a large population-based study by comparing individuals with a history of arterial or venous thrombosis to cardiovascular healthy individuals.

METHODS: This study comprised 502 individuals with a history of arterial disease, 195 with history of venous thrombosis and 1402 cardiovascular healthy individuals (reference group) from the population-based Gutenberg Health Study (GHS). Calibrated Automated Thrombography was assessed and coagulation factors were measured by means of BCS XP Systems. To assess the biochemical determinants of TG variables, a multiple linear regression analysis, adjusted for age, sex and antithrombotic therapy, was conducted.

RESULTS: The lag time, the time to form the first thrombin, was mainly positively associated with the natural coagulant and anti-coagulant factors in the reference group, i.e. higher factors result in a longer lag time. The same determinants were negative for individuals with a history of arterial or venous thrombosis, with a 10 times higher effect size. Endogenous thrombin potential, or area under the curve, was predominantly positively determined by factor II, VIII, X and IX in all groups. However, the effect sizes of the reported associations were 4 times higher for the arterial and venous disease groups in comparison to the reference group.

CONCLUSION: This large-scale analysis demonstrated a stronger effect of the coagulant and natural anti-coagulant factors on the thrombin potential in individuals with a history of arterial or venous thrombosis as compared to healthy individuals, which implicates sustained alterations in the plasma coagulome in subjects with a history of thrombotic vascular disease, despite intake of antithrombotic therapy.

Original languageEnglish
Article number32
Number of pages9
JournalThrombosis Journal
Volume20
Issue number1
DOIs
Publication statusPublished - 8 Jun 2022

Keywords

  • Coagulation factors
  • Thrombin generation
  • Arterial thrombosis
  • Venous thrombosis
  • BLOOD-COAGULATION
  • RISK-FACTORS
  • THROMBOGRAM
  • INHIBITION
  • INCREASE

Cite this